Parkinson's disease - palliative care needs assessment tool: adaptation and psychometric testing.

Chronic conditions Clinical assessment Neurological conditions Supportive care Symptoms and symptom management

Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
26 Jul 2022
Historique:
received: 12 11 2021
accepted: 24 06 2022
entrez: 26 7 2022
pubmed: 27 7 2022
medline: 27 7 2022
Statut: aheadofprint

Résumé

Parkinson's disease is a progressive, life-limiting disease, which benefits from structured palliative care. Systematic recognition and triage of needs helps facilitate care, allows focused referral to specialist palliative care and aids sustainability of services. Existing palliative care tools for Parkinson's are patient/caregiver completed and focus on quantification rather than identification of the need. The Needs Assessment Tool: Progressive Disease in Cancer was designed for rapid identification of unmet needs in cancer. We describe adaptation and psychometric testing of the tool for Parkinson's disease (NAT:Parkinson's disease). Set in secondary care, Parkinson's disease outpatient clinics in the UK, this study included people with Parkinson's, age >18, including all disease stages. People with atypical Parkinsonian syndromes were excluded. Adaptation was made using systematic review and focus groups. Construct validity was tested in 50 consecutive patients against established patient and caregiver measures, analysed with Kendall's Tau B. Inter-rater reliability, using video consultations, were calculated in broad range of clinicians involved in Parkinson's disease care using a weighted kappa; 0-0.2=slight, 0.21-0.40=fair, 0.41-0.60=moderate, 0.61-0.80=substantial and p<0.05 indicative of statistically significant agreement. Validity was substantial for two, moderate for five and fair for four constructs. Inter-rater reliability was substantial for one, moderate for three and fair for six constructs. Two constructs failing to demonstrate fair reliability did show very high percentage agreement. Findings support the suitability of the NAT:Parkinson's disease for everyday clinical use in the identification and triage of unmet palliative need for people with Parkinson's disease.

Identifiants

pubmed: 35882517
pii: spcare-2021-003447
doi: 10.1136/spcare-2021-003447
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Edward William Richfield (EW)

Medicine for Older People, North Bristol NHS Trust, Westbury on Trym, UK Edward.Richfield@nbt.nhs.uk.

Victoria Allgar (V)

Peninsula Clinical Trials Unit, Plymouth University, Plymouth, UK.

Afaf Girgis (A)

South Western Sydney Clinical School, University of NSW, Sydney, New South Wales, Australia.

Miriam J Johnson (MJ)

Wolfson Palliative Care Research Centre, University of Hull, Hull, UK.

Classifications MeSH